Delivery Order SPE2DB24D9315-SPE2DB25FFWLV
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. The delivery order, which expires September 11, 2025, covers 60 tablets of Xtandi 80 mg, an oncology medication used to treat advanced prostate cancer. This award was issued without a set-aside designation, demonstrating the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on August 14, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count supply), an oncology medication used in prostate cancer treatment. This delivery order carries an ultimate completion date of August 15, 2025, and was awarded without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $4,311.35 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 18, 2025, for 120 capsules of Xtandi 40 mg. The delivery order is not designated as a set-aside contract and carries an ultimate completion date of July 21, 2025. This award represents a single delivery transaction executed under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency for the supply of Xtandi 80 mg tablets (60-count units). The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $4,169.59 for 120 tablets of Xtandi 40 mg, a prescription medication commonly used in oncology treatment. The award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This delivery order was issued without a set-aside designation and is scheduled for completion by July 22, 2025, with performance taking place at the contractor's Park Ridge facility. The award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,683.02 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count units), an oncology medication used in cancer treatment, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency on July 29, 2025. The contract calls for the delivery of Xtandi 40 mg capsules (120-count units) with an ultimate completion date of July 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $25,868.10 by the Defense Logistics Agency for the supply of Xtandi 40 mg capsules (120-count units). The contract is firm fixed-price with an ultimate completion date of September 2, 2025, and carries no set-aside designation. This delivery order represents one of numerous pharmaceutical supply contracts issued to DMS Pharmaceutical Group...
- SPE2DB24D9315Indefinite Delivery Contract
- SPE2DB24D9315-SPE2DB25FFWLVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency on September 9, 2025, with an ultimate completion date of September 10, 2025. The delivery order covers 120 tablets of Xtandi 40 mg, an oncology medication used in the treatment of prostate cancer. This award was issued without a set-aside designation, allowing the vendor to compete directly in the federal marketplace. The contract represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contract awards from the Defense Logistics Agency. The company's portfolio demonstrates extensive experience distributing branded and generic prescription drugs, biologics, and specialty medications to Department of Defense healthcare sites worldwide. This particular delivery order exemplifies the vendor's role in supporting military medical supply requirements through the efficient procurement and delivery of essential pharmaceutical products to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/9/25 |